| Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders -> Monitor Keywords |
|
Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disordersPurified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders description/claimsThe Patent Description & Claims data below is from USPTO Patent Application 20090264341, Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders. Brief Patent Description - Full Patent Description - Patent Application Claims The present invention relates to a purified Arabinogalactan-Protein (AGP) composition isolated through a selective method from the leaves and/or stems of Argemone mexicana plant. The present invention also relates to a purified Arabinogalactan-Protein (AGP) composition isolated from the leaves and/or stems of Argemone mexicana plant, which has one or more of the following effects: immunosuppression, lymphoproliferation inhibition, cytokine modulation such as IL-2 inhibition, IFN-γ inhibition, or IL-10 induction; keratinocyte proliferation inhibition, keratolytic activity and inhibitory activity in Mouse Ear Swelling test (MEST). Arabinogalactan-Protein: AGP High Molecular Weight Arabinogalactan-Protein: AGP-HM Low Molecular Weight Arabinogalactan-Protein: AGP-LM Continue reading about Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders... Full patent description for Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders Brief Patent Description - Full Patent Description - Patent Application Claims Click on the above for other options relating to this Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders patent application. Patent Applications in related categories: 20090298749 - Dalbavancin compositions for treatment of bacterial infections - The invention provides methods and compositions for treatment of bacterial infections. The composition may be a combination of factors, which include A0, A1, B1, B2, C0, C1, isoB0, and MAG, in the presence of low level solvent. Methods of the invention include administration of dalbavancin formulations for treatment of a ... 20090298747 - Methods and compositions for treatment of nitric oxide-induced clinical conditions - The present invention provides compositions and methods for modulating cellular nitric oxide (NO) production and for treating a clinical condition associated therewith. ... 20090298748 - Methods of administering dalbavancin for treatment of bacterial infections - The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels ... ### 1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored. 3. Each week you receive an email with patent applications related to your keywords. Start now! - Receive info on patent apps like Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders or other areas of interest. ### Previous Patent Application: Heterocyclic compounds Next Patent Application: Compositions and methods for antibiotic potentiation and drug discovery Industry Class: Drug, bio-affecting and body treating compositions ### FreshPatents.com Support Thank you for viewing the Purified arabinogalactan-protein (agp) composition useful in the treatment psoriasis and other disorders patent info. IP-related news and info Results in 3.14095 seconds Other interesting Feshpatents.com categories: Qualcomm , Schering-Plough , Schlumberger , Seagate , Siemens , Texas Instruments , paws |
* Protect your Inventions * US Patent Office filing
PATENT INFO |
|